These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24555436)

  • 1. Identification of novel microRNA regulatory pathways associated with heterogeneous prostate cancer.
    Tang Y; Yan W; Chen J; Luo C; Kaipia A; Shen B
    BMC Syst Biol; 2013 Oct; 7 Suppl 3(Suppl 3):S6. PubMed ID: 24555436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clear cell renal cell carcinoma associated microRNA expression signatures identified by an integrated bioinformatics analysis.
    Chen J; Zhang D; Zhang W; Tang Y; Yan W; Guo L; Shen B
    J Transl Med; 2013 Jul; 11():169. PubMed ID: 23841900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of candidate miRNA biomarkers from miRNA regulatory network with application to prostate cancer.
    Zhang W; Zang J; Jing X; Sun Z; Yan W; Yang D; Shen B; Guo F
    J Transl Med; 2014 Mar; 12():66. PubMed ID: 24618011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of microRNA-99a-3p in Prostate Cancer Based on Bioinformatics Data and Meta-Analysis of a Literature Review of 965 Cases.
    Yan HB; Zhang Y; Cen JM; Wang X; Gan BL; Huang JC; Li JY; Song QH; Li SH; Chen G
    Med Sci Monit; 2018 Jul; 24():4807-4822. PubMed ID: 29997385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
    Ye Y; Li SL; Wang SY
    PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosome-derived microRNAs contribute to prostate cancer chemoresistance.
    Li J; Yang X; Guan H; Mizokami A; Keller ET; Xu X; Liu X; Tan J; Hu L; Lu Y; Zhang J
    Int J Oncol; 2016 Aug; 49(2):838-46. PubMed ID: 27278879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systems biology approach for miRNA-mRNA expression patterns analysis in non-small cell lung cancer.
    Najafi A; Tavallaei M; Hosseini SM
    Cancer Biomark; 2016; 16(1):31-45. PubMed ID: 26484609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNA-mRNA correlation-network modules in human prostate cancer and the differences between primary and metastatic tumor subtypes.
    Zhang W; Edwards A; Fan W; Flemington EK; Zhang K
    PLoS One; 2012; 7(6):e40130. PubMed ID: 22768240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global gene expression analysis reveals reduced abundance of putative microRNA targets in human prostate tumours.
    Sun R; Fu X; Li Y; Xie Y; Mao Y
    BMC Genomics; 2009 Feb; 10():93. PubMed ID: 19245699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico identification of key genes and signaling pathways targeted by a panel of signature microRNAs in prostate cancer.
    Baruah MM; Sharma N
    Med Oncol; 2019 Apr; 36(5):43. PubMed ID: 30937635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The microRNA signatures: aberrantly expressed miRNAs in prostate cancer.
    Sharma N; Baruah MM
    Clin Transl Oncol; 2019 Feb; 21(2):126-144. PubMed ID: 29951892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene networks and microRNAs implicated in aggressive prostate cancer.
    Wang L; Tang H; Thayanithy V; Subramanian S; Oberg AL; Cunningham JM; Cerhan JR; Steer CJ; Thibodeau SN
    Cancer Res; 2009 Dec; 69(24):9490-7. PubMed ID: 19996289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic Identification of MicroRNAs That Impact on Proliferation of Prostate Cancer Cells and Display Changed Expression in Tumor Tissue.
    Aakula A; Kohonen P; Leivonen SK; Mäkelä R; Hintsanen P; Mpindi JP; Martens-Uzunova E; Aittokallio T; Jenster G; Perälä M; Kallioniemi O; Östling P
    Eur Urol; 2016 Jun; 69(6):1120-8. PubMed ID: 26489476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VDR regulation of microRNA differs across prostate cell models suggesting extremely flexible control of transcription.
    Singh PK; Long MD; Battaglia S; Hu Q; Liu S; Sucheston-Campbell LE; Campbell MJ
    Epigenetics; 2015; 10(1):40-9. PubMed ID: 25494645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activin A regulates microRNAs and gene expression in LNCaP cells.
    Ottley EC; Nicholson HD; Gold EJ
    Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying novel prostate cancer associated pathways based on integrative microarray data analysis.
    Wang Y; Chen J; Li Q; Wang H; Liu G; Jing Q; Shen B
    Comput Biol Chem; 2011 Jun; 35(3):151-8. PubMed ID: 21704261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Potential miRNAs Biomarkers for High-Grade Prostate Cancer by Integrated Bioinformatics Analysis.
    Foj L; Filella X
    Pathol Oncol Res; 2019 Oct; 25(4):1445-1456. PubMed ID: 30367364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diet, microRNAs and prostate cancer.
    Saini S; Majid S; Dahiya R
    Pharm Res; 2010 Jun; 27(6):1014-26. PubMed ID: 20221895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model.
    Lin Y; Chen F; Shen L; Tang X; Du C; Sun Z; Ding H; Chen J; Shen B
    J Transl Med; 2018 May; 16(1):134. PubMed ID: 29784056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prioritizing candidate disease miRNAs by topological features in the miRNA target-dysregulated network: case study of prostate cancer.
    Xu J; Li CX; Lv JY; Li YS; Xiao Y; Shao TT; Huo X; Li X; Zou Y; Han QL; Li X; Wang LH; Ren H
    Mol Cancer Ther; 2011 Oct; 10(10):1857-66. PubMed ID: 21768329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.